Rodney A. Prell

2.2k total citations
24 papers, 1.3k citations indexed

About

Rodney A. Prell is a scholar working on Immunology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Rodney A. Prell has authored 24 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 7 papers in Oncology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Rodney A. Prell's work include Immunotherapy and Immune Responses (13 papers), T-cell and B-cell Immunology (8 papers) and CAR-T cell therapy research (7 papers). Rodney A. Prell is often cited by papers focused on Immunotherapy and Immune Responses (13 papers), T-cell and B-cell Immunology (8 papers) and CAR-T cell therapy research (7 papers). Rodney A. Prell collaborates with scholars based in United States, Switzerland and United Kingdom. Rodney A. Prell's co-authors include Andrew D. Weinberg, Anthony T. Vella, Joseph R. Maxwell, Walter J. Urba, Dean E. Evans, Colin Thalhofer, Karin Jooss, Nancy I. Kerkvliet, Gregory Alvord and Campbell Bunce and has published in prestigious journals such as The Journal of Immunology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Rodney A. Prell

23 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rodney A. Prell United States 15 1.0k 563 220 143 70 24 1.3k
Drew M. Pardoll United States 8 731 0.7× 426 0.8× 319 1.4× 72 0.5× 62 0.9× 16 1.1k
Paul Hobby United Kingdom 16 954 1.0× 344 0.6× 218 1.0× 168 1.2× 32 0.5× 24 1.3k
Emma F. Barry Australia 14 396 0.4× 346 0.6× 360 1.6× 44 0.3× 47 0.7× 18 942
Kristin Andreassen Fenton Norway 19 742 0.7× 219 0.4× 210 1.0× 206 1.4× 30 0.4× 35 1.2k
Jason B. Muhitch United States 14 649 0.6× 628 1.1× 281 1.3× 43 0.3× 89 1.3× 33 1.2k
Kelly P. Burke United States 10 333 0.3× 468 0.8× 197 0.9× 45 0.3× 125 1.8× 14 826
Soi Cheng Law Australia 12 598 0.6× 203 0.4× 222 1.0× 211 1.5× 35 0.5× 27 1.1k
Jin‐Hao Yang China 12 502 0.5× 519 0.9× 286 1.3× 59 0.4× 85 1.2× 27 955
Julien Faget France 17 1.2k 1.2× 804 1.4× 279 1.3× 47 0.3× 105 1.5× 22 1.5k
Avi Eisenthal Israel 17 558 0.6× 241 0.4× 237 1.1× 138 1.0× 21 0.3× 53 846

Countries citing papers authored by Rodney A. Prell

Since Specialization
Citations

This map shows the geographic impact of Rodney A. Prell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rodney A. Prell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rodney A. Prell more than expected).

Fields of papers citing papers by Rodney A. Prell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rodney A. Prell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rodney A. Prell. The network helps show where Rodney A. Prell may publish in the future.

Co-authorship network of co-authors of Rodney A. Prell

This figure shows the co-authorship network connecting the top 25 collaborators of Rodney A. Prell. A scholar is included among the top collaborators of Rodney A. Prell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rodney A. Prell. Rodney A. Prell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sutaria, Dhruvitkumar S., Rodney A. Prell, Wendy Halpern, et al.. (2025). Quantifying Risk of Delayed QT Prolongation of Ipatasertib in Preclinical and Clinical Studies in Cancer Patients. Clinical and Translational Science. 18(7). e70298–e70298. 1 indexed citations
2.
Grimaldi, Christine, Andrea Kießling, Benno Rattel, et al.. (2022). Current nonclinical approaches for immune assessments of immuno-oncology biotherapeutics. Drug Discovery Today. 28(2). 103440–103440. 3 indexed citations
3.
4.
Slaga, Dionysos, Diego Ellerman, T. Noelle Lombana, et al.. (2018). Avidity-based binding to HER2 results in selective killing of HER2-overexpressing cells by anti-HER2/CD3. Science Translational Medicine. 10(463). 93 indexed citations
5.
Prell, Rodney A., et al.. (2018). Placental and Fetal Effects of Onartuzumab, a Met/HGF Signaling Antagonist, When Administered to Pregnant Cynomolgus Monkeys. Toxicological Sciences. 165(1). 186–197. 6 indexed citations
6.
Finco, Deborah, Christine Grimaldi, Madeline Fort, et al.. (2014). Cytokine release assays: Current practices and future directions. Cytokine. 66(2). 143–155. 64 indexed citations
7.
Prell, Rodney A., Wendy Halpern, Joseph C. Beyer, et al.. (2014). 424 Nonclinical safety assessment of a humanized anti-OX40 agonist antibody, MOXR0916. European Journal of Cancer. 50. 136–136. 1 indexed citations
8.
Bahjat, Keith S., Rodney A. Prell, Heather E. Allen, et al.. (2007). Activation of Immature Hepatic NK Cells As Immunotherapy for Liver Metastatic Disease. The Journal of Immunology. 179(11). 7376–7384. 21 indexed citations
9.
Brockstedt, Dirk G., Meredith L. Leong, Keith S. Bahjat, et al.. (2007). Live-attenuated L. monocytogenes encoding mesothelin for immunotherapy of patients with pancreas and ovarian cancers. 67. 1874–1874. 3 indexed citations
10.
Prell, Rodney A., et al.. (2006). The anti-tumor efficacy of a GM-CSF-secreting tumor cell vaccine is not inhibited by docetaxel administration. Cancer Immunology Immunotherapy. 55(10). 1285–1293. 26 indexed citations
11.
Chu, Yiwei, Guojun Yang, Helen J. Ross, et al.. (2006). Efficacy of GM-CSF-producing Tumor Vaccine after Docetaxel Chemotherapy in Mice Bearing Established Lewis Lung Carcinoma. Journal of Immunotherapy. 29(4). 367–380. 58 indexed citations
12.
Prell, Rodney A., et al.. (2005). Administration of IFN-α Enhances the Efficacy of a Granulocyte Macrophage Colony Stimulating Factor–Secreting Tumor Cell Vaccine. Cancer Research. 65(6). 2449–2456. 19 indexed citations
13.
Weinberg, Andrew D., et al.. (2004). The generation of T cell memory: a review describing the molecular and cellular events following OX40 (CD134) engagement. Journal of Leukocyte Biology. 75(6). 962–972. 47 indexed citations
14.
Prell, Rodney A., et al.. (2003). OX40-Mediated Memory T Cell Generation Is TNF Receptor-Associated Factor 2 Dependent. The Journal of Immunology. 171(11). 5997–6005. 63 indexed citations
15.
Evans, Dean E., Rodney A. Prell, Colin Thalhofer, Arthur A. Hurwitz, & Andrew D. Weinberg. (2001). Engagement of OX40 Enhances Antigen-Specific CD4+ T Cell Mobilization/Memory Development and Humoral Immunity: Comparison of αOX-40 with αCTLA-4. The Journal of Immunology. 167(12). 6804–6811. 82 indexed citations
16.
Weinberg, Andrew D., Rodney A. Prell, Arden M. Morris, et al.. (2000). Engagement of the OX-40 Receptor In Vivo Enhances Antitumor Immunity. The Journal of Immunology. 164(4). 2160–2169. 315 indexed citations
17.
Maxwell, Joseph R., Andrew D. Weinberg, Rodney A. Prell, & Anthony T. Vella. (2000). Danger and OX40 Receptor Signaling Synergize to Enhance Memory T Cell Survival by Inhibiting Peripheral Deletion. The Journal of Immunology. 164(1). 107–112. 188 indexed citations
18.
Prell, Rodney A., et al.. (2000). CTL Hyporesponsiveness Induced by 2,3,7,8-Tetrachlorodibenzo-p-dioxin: Role of Cytokines and Apoptosis. Toxicology and Applied Pharmacology. 166(3). 214–221. 20 indexed citations
19.
Prell, Rodney A. & Nancy I. Kerkvliet. (1997). Involvement of altered B7 expression in dioxin immunotoxicity: B7 transfection restores the CTL but not the autoantibody response to the P815 mastocytoma. The Journal of Immunology. 158(6). 2695–2703. 32 indexed citations
20.
Prell, Rodney A., et al.. (1995). Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on anti-CD3-induced changes in T-cell subsets and cytokine production. International Journal of Immunopharmacology. 17(11). 951–961. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Drew M. Pardoll Breakdown of academic impact, for papers by Paul Hobby Breakdown of academic impact, for papers by Emma F. Barry Breakdown of academic impact, for papers by Kristin Andreassen Fenton Breakdown of academic impact, for papers by Jason B. Muhitch Breakdown of academic impact, for papers by Kelly P. Burke Breakdown of academic impact, for papers by Soi Cheng Law Breakdown of academic impact, for papers by Jin‐Hao Yang Breakdown of academic impact, for papers by Julien Faget Breakdown of academic impact, for papers by Avi Eisenthal
Rankless by CCL
2026